Delivery Order SPE2DR25D7067-SPE2DR26FW4EJ
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $26,653.85 to AmerisourceBergen Drug Corp for the supply of Latuda 40 mg tablets (30-count units) under a firm fixed-price contract type. The award was made on November 13, 2025, with an ultimate completion date of November 14, 2025, and represents a non-competitive, non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location....
- The Defense Logistics Agency awarded a delivery order valued at $5,381.64 to AmerisourceBergen Drug Corp for the supply of Latuda 120 mg tablets (30-count packages) under a firm fixed-price contract. The order was competitively awarded without set-aside designation and is scheduled for completion by January 6, 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Latuda 40 mg tablets (30-count units) valued at $7,754.48 under a firm fixed price contract structure. This non-set-aside award was competitively procured and is scheduled for completion by July 15, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and will fulfill this order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Latuda 20 mg tablets (30-count) valued at $4,191.82 under a firm fixed-price contract. The award was made on May 14, 2025, with an ultimate completion date of May 15, 2025, and the product will be performed from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This is a non-set-aside competitive award, reflecting the contractor's established capability to meet federal pharmaceutical procurement...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Latuda 80 mg tablets (30-count units) with a ceiling value of $5,922.45. This firm fixed-price delivery order, with an ultimate completion date of September 24, 2025, represents a single transaction under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. The award was competitively procured with no set-aside designation, and...
- The Defense Logistics Agency awarded a delivery order valued at $6,295.43 to AmerisourceBergen Drug Corp for the supply of Latuda 80 mg tablets (30-count units). This firm fixed-price, non-set-aside contract was awarded on December 11, 2025, with an ultimate completion date of December 12, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Latuda 60 mg tablets (30-count units) under a firm fixed-price contract valued at $2,957.95. This non-competitive delivery order was issued on December 30, 2025, with an ultimate completion date of December 31, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a small-value transaction within...
- The Defense Logistics Agency awarded a delivery order valued at $50,064.71 to AmerisourceBergen Drug Corp for the supply of Latuda 120 mg tablets (30-count units). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 19, 2025, issued on September 18, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Latuda 80 mg tablets (30-count) on September 25, 2025, with a ceiling value of $19,403.50. This is a firm fixed-price delivery order with an ultimate completion date of September 26, 2025, performed at the contractor's Conshohocken, Pennsylvania location. The award represents a non-competitive delivery against AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order on September 2, 2025, for the supply of Latuda 60 mg tablets (30-count packaging) with a ceiling value of $6,445.00 under a firm fixed price contract. This non-set-aside award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, which carries a total value of $999,999,999.00 and extends through December 2026. The order is to be fulfilled...
- SPE2DR25D7067Indefinite Delivery Contract
- SPE2DR25D7067-SPE2DR26FW4EJDelivery Order
The Defense Logistics Agency awarded a delivery order valued at approximately $29.2K to AmerisourceBergen Drug Corp for the supply of Latuda 20 mg tablets (30-count packages) on January 27, 2026, with a completion date of January 28, 2026. This competitive, non-set-aside award was issued under firm fixed-price terms and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving federal healthcare systems, particularly the military medical supply chain. This delivery order is executed under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.9M through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the delivery of specialty medications, brand-name and generic drugs, vaccines, and related medical supplies to support military healthcare programs worldwide, including the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. Latuda is a neuropsychiatric medication, consistent with the contractor's portfolio of pharmaceutical products spanning multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $29.2k | 1/26/26 |